Natalizumab Biosimilar to Get FDA Review for MS, Crohn Disease Indications
The application is under review for relapsing forms of multiple sclerosis and Crohn disease.
Multiple Sclerosis
Lavender Capsule Combats Fatigue in Patients With Multiple Sclerosis
Researchers sought to determine the efficacy of a lavender capsule on reducing fatigue symptoms in patients with MS.
Cannabis-Derived Oromucosal Spray Misses in MS Spasticity Trial
The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis.
TMS for Multiple Sclerosis: Can It Help Treat Depressive Symptoms?
In a quantitative study, researchers assessed the efficacy of TMS on depressive symptoms in people with MS.
Neurofilament Light Chain Levels May Predict Multiple Sclerosis Disease Activity
Presenting at CMSC 2022, researchers evaluated the prognostic value of baseline NfL for predicting clinical relapse and change in MRI lesion activity among patients with MS.
Lyvispah Now Available for Spasticity Due to MS, Other Spinal Cord Disorders
The approval was based upon a bioavailability study in healthy adults comparing baclofen oral tablets to Lyvispah.
FDA Changes Decision Date for Investigational MS Drug Ublituximab
The FDA extended the action date to allow time to review a submission provided by the Company.
Can Childhood Trauma Increase the Risk for Multiple Sclerosis in Women?
In a prospective cohort study, researchers assessed whether adverse childhood experiences may increase the risk for multiple sclerosis in women.
MAMS Adaptive Trial Shows Promise for Future Progressive MS Treatments
Nurulamin Noor, MD, discusses the advantages and challenges of a MAMS adaptive trial design for PMS.
Ublituximab Shows Benefit Among Patients With Relapsing Multiple Sclerosis
Using data from the Ultimate I and II phase 3 trials, researchers conducted a post-hoc analysis to study the effects of ublituximab on disease activity in relapsing multiple sclerosis.
- Loading...
Loading...
Next post in Neurology
Loading... 
Loading...